openPR Logo
Press release

NavigaWaldenstrom Macroglobulinemia Market Projected to Discern Stable Expansion During 2018 to 2026

01-15-2019 08:08 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

NavigaWaldenstrom Macroglobulinemia Market Projected

Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum, which leads to increased serum viscosity, and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to excess amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to symptoms. In the last few years, medical science has made much progress and a number of new treatments for this type of cancer have been introduced. However, very few studies have been done to compare the treatment options and thus, discover the best available option. Hence, there is no single treatment available that works for all patients. Symptomatic Waldenstrom macroglobulinemia patients are kept under observation and do not receive any treatment until symptoms show up.

Patients showing symptoms, such as anemia, hyperviscosity, cold-agglutinin disease, amyloidosis, peripheral neuropathy, etc., are considered for the treatment. Patients that show symptomatic hyperviscosity receive plasmapheresis along with rituximab treatment. In most cases of Waldenstrom macroglobulinemia, combination therapy with chemo and immunotherapy is recommended. Patients with this type of cancer may require stem cell transplantation during the latter stage. Hence, standard chemotherapy agents, such as chlorambucil, bendamustine, cladribine or fludarabine, etc., are not prescribed as first line therapy as they may affect the stem cells. 

Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=2580 

Waldenstrom macroglobulinemia Market: Drivers and Restraints

Improving treatment options and diagnosis rate are the major factors expected to drive the growth of the Waldenstrom macroglobulinemia treatment market over the forecast period. Researchers have found that targeted therapy agents, such as Velcade and Kyprolis, show improved treatment outcomes. Increased treatment seeking rate is another important factor driving the growth of the global Waldenstrom macroglobulinemia treatment market. However, lack of a single standard treatment for all patients and disease complexity are the major factors limiting the growth of global Waldenstrom macroglobulinemia treatment market. High cost of therapy and side effects are some other factors that can hamper the treatment seeking rates and in turn, affect the global market growth. 

Waldenstrom macroglobulinemia Market: Segmentation

The global Waldenstrom macroglobulinemia market can be segmented on the basis of treatment, distribution channel and geography.

Based on treatment, the global Waldenstrom macroglobulinemia market is segmented as:

Chemotherapy
Alkylating agents
Cyclophosphamide (Cytoxan)
Bendamustine (Treanda)
Purine analogs
Fludarabine (Fludara)
Cladribine (2-CdA, Leustatin)
Corticosteroids
Prednisone
Dexamethasone (Decadron)
Others
Vincristine (Oncovin)
Doxorubicin (Adriamycin)
Targeted Therapy
Proteasome Inhibitors (bortezomib, carfilzomib)
mTOR inhibitors (Everolimus)
Bruton tyrosine kinase (BTK) inhibitors (ibrutinib)
Biological/immunotherapy
Monoclonal antibodies (rituximab, ofatumumab, alemtuzumab)
Immunomodulating Agents (Pomalidomide, Thalidomide)
Cytokines (Interfero)
Plasmapheresis
Stem Cell Transplantation
Based on distribution channel, the global Waldenstrom macroglobulinemia market is segmented as:

Hospitals
Specialty Cancer Clinics 
Waldenstrom macroglobulinemia Market: Overview

The global market for Waldenstrom macroglobulinemia is expected to witness moderate growth over the forecast period. The targeted therapy segment is expected to witness considerable growth during the forecast period due to increased adoption rate of Waldenstrom macroglobulinemia targeted therapy drugs. Hospitals are the preferred distribution channel for due to requirement of skilled professionals for planning of Waldenstrom macroglobulinemia treatment. Besides, other therapies, such as stem cell transplantation, require highly advanced medical infrastructure. Majority of these treatments are covered under medical part B and hence, hospitals are a preferred distribution channel for Waldenstrom macroglobulinemia treatments.

Request Full Report With TOC: https://www.factmr.com/connectus/sample?flag=T&rep_id=2580 

Waldenstrom macroglobulinemia Market: Regional Outlook

Geographically, the global Waldenstrom macroglobulinemia market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global Waldenstrom macroglobulinemia market owing to high prevalence of the disease and better availability of medical resources in the region. The Waldenstrom macroglobulinemia market in Asia Pacific excluding Japan is expected to grow at a slow rate. Europe is expected to hold second largest share in the global Waldenstrom macroglobulinemia market throughout the forecast period. 

Waldenstrom macroglobulinemia Market: Key Players

Some of the players identified in the global include Baxter International Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Janssen Pharmaceutica NV (Johnson & Johnson), Merck & Co Inc., Hospira (Pfizer Inc.), Takeda Pharmaceutical Company Limited., Amgen Inc., Novartis AG and (Genentech) F. Hoffman-La Roche AG, among others. 

Grow Your Business From Expert Advice: https://www.factmr.com/report/2580/navigawaldenstrom-macroglobulinemia-market 

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release NavigaWaldenstrom Macroglobulinemia Market Projected to Discern Stable Expansion During 2018 to 2026 here

News-ID: 1497481 • Views: 260

More Releases from Fact.MR

Sichuan Peppercorn Market 2030 Report Enlightening Development Scope and Busines …
The Recent study by Fact.MR– (leading business and competitive intelligence provider) On global Sichuan Peppercorn market Survey study presents an all in all compilation of the historical, current and future outlook of Sichuan Peppercorn market as well as the factors responsible for such a Sichuan Peppercorn Market growth. The report on the market survey of Sichuan Peppercorn gives estimations of the Size of Sichuan Peppercorn Market and the overall share of
The Global Demand of Halal Transportation Logistics Market, Growth Analysis, Lat …
Worldwide, the Muslim population has been growing at nearly 2% each year, nearly double the growth of the overall global population. This has been consequently adding revenues to the products and services designed under the periphery of Islamic laws. According to a State of the Global Economy report, the Muslim population is expected to spend US$ 3 Tn by 2021, up from US$ 1.9 Tn in 2015. In the U.S. alone,
Sales Forecast of Die Cut Handle Bags Market , Analysis, and Forecast Report til …
The global carry bags market is anticipated to reach a valuation of over US$ 30 billion in 2030, with the growth rate pegged at over 4%. The foodservice industry, being the major revenue attributer for carry bags, remained closed during the first two quarters of 2020, due to the widespread of the COVID-19 outbreak. But it is expected that, the global carry bags market will return to its normal growth
The Global Demand Of Salt Spray Chamber Market, Growth Analysis, Latest Trends A …
The Recent study by Fact.MR– (leading business and competitive intelligence provider) On global Salt Spray Chamber market Survey study presents an all in all compilation of the historical, current and future outlook of Salt Spray Chamber market as well as the factors responsible for such a Salt Spray Chamber Market growth. The report on the market survey of Salt Spray Chamber gives estimations of the Size of Salt Spray Chamber Market

All 5 Releases


More Releases for Waldenstrom

Research Offers 08-Year Forecast on Waldenstrom Macroglobulinemia Market(Chemoth …
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few
04-22-2019 | Health & Medicine
Fact.MR
Waldenstrom Macroglobulinemia Market key Insights Based on Product Type, End-use …
Researchers have found that targeted therapy agents such as Velcade and Kyprolis are showing improved outcomes. Increased treatment-seeking rate is the other important factor projected to drive the growth of the global Waldenstrom Macroglobulinemia Market. However, lack of single standard treatment for all patients and disease complexity are the major factors expected to limit the growth of the global Waldenstrom macroglobulinemia market. High cost of therapy and side effects are
NavigaWaldenstrom Macroglobulinemia Market Expected to Deliver Dynamic Progressi …
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum, which leads to increased serum viscosity, and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to excess amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to symptoms. In the last few years, medical science has made much
Waldenstrom Macroglobulinemia Market Challenges Analysis by 2026
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few
Waldenstrom Macroglobulinemia Market | Key Players - Baxter International Inc., …
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few
Waldenstrom Macroglobulinemia Market Trends, Regulations And Competitive Landsca …
Waldenstrom macroglobulinemia is a rare cancer and is characterized by high level of immunoglobulin M (IgM) in the serum that causes increased serum viscosity and presence of a lymphoplasmacytic infiltrate in the bone marrow. Waldenstrom macroglobulinemia starts in B cells or B lymphocytes and leads to form large amount of IgM. Treatment options for Waldenstrom macroglobulinemia vary according to the symptoms, although standard treatments are available. In the last few